Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine

• Status: Not yet recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study is an open-label randomized controlled trial of the efficacy of the integration of Traditional Chinese medicine (TCM) and western medicine based on TCM syndrome differentiation. The hypothesis is (1) TCM model can identify the primary and secondary type burning mouth syndrome (BMS); (2) TCM model can identify BMS after treatment with western medicine; (3) There is a positive effect of TCM in treating BMS.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chang Gung Memorial Hospital
• Collaborator: Ministry of Science and Technology, Taiwan
• Treatments: Clonazepam

Criteria

Inclusion Criteria:

1. Participants who signed the informed consent

2. The clinical diagnosis was primary or secondary type BMS patient

3. ≥ 20-year-old

4. Female

5. Willing to take Traditional Chinese Medicine

Exclusion Criteria:

1. History of an angiotensin-converting enzyme inhibitor (ACEI) taking

2. Autoimmune disease

3. Poor kidney function

4. Unwilling to take Traditional Chinese Medicine

5. Male

6. Participants who have been treated with TCM or Acupuncture within a month

7. Participants who have been treated with medicine for burning mouth syndrome